AACC, August 4-8, 2019, Anaheim, CA, Booth 4309
APHL, June 3-6, 2019, St. Louis, MO, Booth 334-336
ASM Biothreats, January 29-31, 2019, Arlington, VA, Booth 26
InBios Receives FDA Market Authorization for its ZIKV Detect 2.0 IgM Capture ELISA for a Presumptive Diagnosis of Zika Virus Infection
FDA Grants Marketing Authorization for First Diagnostic Test for Detecting Zika IgM Antibodies to InBios
InBios announces FDA clearance of its Dengue NS1 ELISA kit
Your information will be kept private.